Total Payments
$594,864
2024 Payments
$94,280
Companies
43
Transactions
1,400
Payment Breakdown by Category
Other$373,480 (62.8%)
Consulting$144,837 (24.3%)
Travel$39,925 (6.7%)
Food & Beverage$29,404 (4.9%)
Research$6,940 (1.2%)
Education$278.24 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $351,630 | 119 | 59.1% |
| Consulting Fee | $144,837 | 43 | 24.3% |
| Travel and Lodging | $39,925 | 168 | 6.7% |
| Food and Beverage | $29,404 | 1,047 | 4.9% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $13,400 | 4 | 2.3% |
| Honoraria | $8,450 | 6 | 1.4% |
| Unspecified | $6,940 | 5 | 1.2% |
| Education | $278.24 | 8 | 0.0% |
Payments by Type
General
$587,924
1,395 transactions
Research
$6,940
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $214,690 | 287 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $113,366 | 212 | $0 (2024) |
| Galderma Laboratories, L.P. | $67,399 | 156 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $48,547 | 14 | $0 (2020) |
| PFIZER INC. | $32,892 | 82 | $0 (2024) |
| Dermavant Sciences, Inc. | $25,979 | 23 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $18,155 | 76 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $11,401 | 19 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $9,831 | 10 | $0 (2022) |
| ABBVIE INC. | $8,070 | 106 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $94,280 | 227 | GENZYME CORPORATION ($46,452) |
| 2023 | $83,761 | 243 | GENZYME CORPORATION ($41,250) |
| 2022 | $67,942 | 214 | GENZYME CORPORATION ($50,178) |
| 2021 | $40,614 | 94 | GENZYME CORPORATION ($16,055) |
| 2020 | $95,872 | 147 | Regeneron Healthcare Solutions, Inc. ($29,966) |
| 2019 | $117,567 | 173 | GENZYME CORPORATION ($35,589) |
| 2018 | $53,370 | 142 | Galderma Laboratories, L.P. ($18,317) |
| 2017 | $41,457 | 160 | PFIZER INC. ($17,169) |
All Payment Transactions
1,400 individual payment records from CMS Open Payments — Page 1 of 56
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: DERMATOLOGY | ||||||
| 12/23/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $13.76 | General |
| Category: Dermatology | ||||||
| 12/19/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $24.97 | General |
| 12/18/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $2.57 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $8.00 | General |
| 12/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $29.71 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Inflammation | ||||||
| 12/09/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Inflammation & Immunology | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.61 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.94 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | Krystal Biotech Inc | VYJUVEK (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: DERMATOLOGY | ||||||
| 12/02/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Immunology | ||||||
| 12/02/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $10.09 | General |
| Category: DERMATOLOGY | ||||||
| 11/26/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $8.05 | General |
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,697.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.16 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/14/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $7.30 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.11 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: Inflammation & Immunology | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,697.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Patient-reported Outcomes for Sarecycline Effectiveness and Safety (PROSES) | Almirall LLC | $3,540 | 2 |
| A PHASE 3 DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY SAFETY AND PHARMACOKINETICS (PK) OF BARICITINIB IN CHILDREN FROM 6 YEARS TO LESS THAN 18 YEARS OF AGE WITH ALOPECIA AREATA | Eli Lilly and Company | $2,700 | 1 |
| PROTOPIC APPLES | LEO Pharma AS | $700.00 | 2 |
About Dr. Fred Ghali, MD
Dr. Fred Ghali, MD is a Dermatology healthcare provider based in Grapevine, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639286339.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fred Ghali, MD has received a total of $594,864 in payments from pharmaceutical and medical device companies, with $94,280 received in 2024. These payments were reported across 1,400 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($351,630).
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Pediatric Dermatology
- Location Grapevine, TX
- Active Since 08/25/2006
- Last Updated 07/28/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639286339
Products in Payments
- DUPIXENT (Biological) $310,555
- DUPIXENT (Drug) $68,486
- EPIDUO FORTE (Drug) $34,102
- EUCRISA (Drug) $32,302
- AKLIEF (Drug) $29,698
- TAPINAROF (Drug) $25,488
- ONEXTON (Drug) $17,470
- COSENTYX (Biological) $9,831
- OPZELURA (Drug) $4,125
- Seysara (Drug) $3,825
- Sitavig (Drug) $3,757
- Cloderm Cream (Drug) $2,773
- Promiseb Complete (Device) $2,663
- RINVOQ (Biological) $2,354
- SEYSARA (Drug) $1,800
- TWYNEO (Drug) $1,300
- YCANTH (Drug) $1,217
- TALTZ (Drug) $867.36
- Sernivo Spray 120ml (Drug) $790.92
- PROTOPIC (Drug) $700.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.